Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor-stimulated gene-6 (TSG-6) is a secreted protein that is upregulated in response to proinflammatory mediators. It has anti-inflammatory and chondroprotective effects, acting as part of a negative feedback loop that downregulates excessive inflammation. TSG-6 binds hyaluronan, a key extracellular matrix component, and interacts with inter-alpha-inhibitor proteins, enhancing their anti-protease activity, contributing to tissue protection during inflammation. It plays a role in various biological processes including ovulation.
Modulates inflammation by binding hyaluronan and interacting with inter-alpha-inhibitor proteins, leading to decreased inflammation and tissue protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor necrosis factor-stimulated gene-6 (TSG-6).